Scopolamine, also known as hyoscine, is available as a transdermal patch called Transderm ScopĀ®. It comes in 1.5 mg dose that releases about 1 mg over a 72 hours period to reduce excessive saliva and oral secretions.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Excess saliva | 18 |
|
1 | ||||
| Vertigo | 3 |
|
1 | ||||
| Drooling | 2 |
|
1 | ||||
| Other | 1 |
|
1 | ||||
| disease-related symptoms | 1 | 0 | |||||
| dry secretions | 1 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
7 | 58% |
|
|
Side effects too severe
|
3 | 25% |
|
|
Other
|
2 | 17% |
|
|
Expense
|
1 | 8% |
|
|
Not indicated
|
1 | 8% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 21, 2009.